Skip to content

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

FTSE 100 drops, Dow remains bid and Nikkei 225 makes new 34-year high

​​Outlook on FTSE 100, Dow and Nikkei 225 as earnings season is quieting down.

Source: Bloomberg

​​​FTSE 100 drops on AstraZeneca disappointment ​

​The FTSE 100 has been rapidly declining from this week’s 7,710 Wednesday high amid disappointing UK company earnings with AstraZeneca on Thursday wiping off around 40 points on the FTSE 100 and the index slipping to the 55-day simple moving average (SMA) at 7,603 and Thursday’s 7,590 low. ​A tumble through 7,590 would push the 200-day SMA at 7,548 to the fore, together with the mid-November and early December highs at 7,543 to 7,535. ​Minor resistance sits at Wednesday’s 7,626 low.

Source: ProRealTime

Dow trades close to record highs

​The Dow Jones Industrial Average, unlike its peers like the Nasdaq 100 and the S&P 500, hasn’t managed to make a new record high this week as yet but continues to grind higher towards the 38,800 region ahead of the major psychological 40,000 mark as the US economy and employment remain strong. ​ In case of a retracement being seen, the 31 January high at 38,583 and the October to February uptrend line at 38,470 may be revisited. While no fall through the second to last daily reaction low at the 1 February at 38,105 is seen, the medium-term uptrend remains intact.

Source: ProRealTime

​The Nikkei 225 scales new 34-year high

​The Nikkei 225 has resumed its ascent and has risen to a new 34-year high at 37,293, a rise above which would put the psychological 40,000 mark on the cards. ​First, though, the January peak at 37,003 would need to be once again exceeded on a daily chart closing basis. ​Were a retracement lower to be seen, however, last week’s high at 36,511 should act as at least interim support.

Source: ProRealTime

Related articles

Live prices on most popular markets

  • Equities
  • Indices
  • Forex
  • Commodities
website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

" >


Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Monday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.


You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.


This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.